BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 10668915)

  • 1. Potent beta-cell protection in vitro by an isoquinolinone-derived PARP inhibitor.
    Burkart V; Blaeser K; Kolb H
    Horm Metab Res; 1999 Dec; 31(12):641-4. PubMed ID: 10668915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of independent mechanism upon poly(ADP-ribose) polymerase (PARP) activation in methylmercury cytotoxicity in rat cerebellar granule cell culture.
    Sakaue M; Mori N; Okazaki M; Ishii M; Inagaki Y; Iino Y; Miyahara K; Yamamoto M; Kumagai T; Hara S; Yamamoto M; Arishima K
    J Neurosci Res; 2008 Nov; 86(15):3427-34. PubMed ID: 18627028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion.
    Radons J; Heller B; Bürkle A; Hartmann B; Rodriguez ML; Kröncke KD; Burkart V; Kolb H
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1270-7. PubMed ID: 8147870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells.
    Kehe K; Raithel K; Kreppel H; Jochum M; Worek F; Thiermann H
    Arch Toxicol; 2008 Jul; 82(7):461-70. PubMed ID: 18046540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and B-cell function of mouse pancreatic islets maintained in culture after concomitant exposure to streptozotocin and nicotinamide.
    Strandell E; Eizirik DL; Sandler S
    Exp Clin Endocrinol; 1989 May; 93(2-3):219-24. PubMed ID: 2528468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia.
    Moroni F; Meli E; Peruginelli F; Chiarugi A; Cozzi A; Picca R; Romagnoli P; Pellicciari R; Pellegrini-Giampietro DE
    Cell Death Differ; 2001 Sep; 8(9):921-32. PubMed ID: 11526447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP inhibition reduces acute colonic inflammation in rats.
    Sánchez-Fidalgo S; Villegas I; Martín A; Sánchez-Hidalgo M; Alarcón de la Lastra C
    Eur J Pharmacol; 2007 Jun; 563(1-3):216-23. PubMed ID: 17374531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
    Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
    Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
    Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia.
    Chiarugi A; Meli E; Calvani M; Picca R; Baronti R; Camaioni E; Costantino G; Marinozzi M; Pellegrini-Giampietro DE; Pellicciari R; Moroni F
    J Pharmacol Exp Ther; 2003 Jun; 305(3):943-9. PubMed ID: 12606624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of poly (ADP-ribose) polymerase as a protective effect of nicaraven in ionizing radiation- and ara-C-induced cell death.
    Watanabe M; Akiyama N; Sekine H; Mori M; Manome Y
    Anticancer Res; 2006; 26(5A):3421-7. PubMed ID: 17094462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different basal NAD levels determine opposite effects of poly(ADP-ribosyl)polymerase inhibitors on H2O2-induced apoptosis.
    Coppola S; Nosseri C; Maresca V; Ghibelli L
    Exp Cell Res; 1995 Dec; 221(2):462-9. PubMed ID: 7493646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells.
    Gao Y; Parker GJ; Hart GW
    Arch Biochem Biophys; 2000 Nov; 383(2):296-302. PubMed ID: 11185566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
    Iwashita A; Mihara K; Yamazaki S; Matsuura S; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1114-24. PubMed ID: 15113847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide in type 1 diabetes. Mechanism of action revisited.
    Kolb H; Burkart V
    Diabetes Care; 1999 Mar; 22 Suppl 2():B16-20. PubMed ID: 10097894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase inhibition in oxidant-stressed endothelial cells prevents oncosis and permits caspase activation and apoptosis.
    Walisser JA; Thies RL
    Exp Cell Res; 1999 Sep; 251(2):401-13. PubMed ID: 10471325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of poly(ADP-ribose) polymerase increase antibody class switching.
    Shockett P; Stavnezer J
    J Immunol; 1993 Dec; 151(12):6962-76. PubMed ID: 8258703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.